XZXiaoqian Zhang

Xiaoqian Zhang

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Xiaoqian Zhang has a total of 16 co-authors. Here are the top co-authors by number of shared publications:

  • Chengguang Song

    Benxi Central Hospital of China Medical University

    1 shared publication
  • Chuansheng Zhao

    Department of Neurology (C. Zhao, S.Z.), First Hospital of China Medical University, Shenyang, Liaoning

    1 shared publication
  • Jing Liu

    Department of Neonatology and NICU, Beijing Obstetrics and Gynecology Hospital, Capital Medical University, Beijing Maternal and Child Health Care Hospital, China

    1 shared publication
  • Jingkuan Sun

    Shandong Key Laboratory of Eco-Environmental Science for the Yellow River Delta, Shandong University of Aeronautics, Binzhou, China

    1 shared publication
  • Junlong Jiu

    School of Postgraduate, Liaoning University of Traditional Chinese Medicine

    1 shared publication
  • Mei Zhao

    Department of Cardiology, The Shengjing Affiliated Hospital, China Medical University, Shenyang, 110004 Liaoning, China

    1 shared publication

Latest Publications

  • Open Access

    Four alkaloids from Portulaca oleracea L. and their anti-inflammatory

    by Jing Liu, Junlong Jiu, Xiaoqian Zhang, Jingkuan Sun, Xixiang Ying

    Four alkaloids were isolated from Portulaca oleracea L., including two new compounds, 2-(4-amino-6-hydroxy-1,6-dihydropyrimidin-5-yl)-5-(hydroxymethyl)tetrahydrofuran-3,4-diol, named Olerapyrimidine (1) and (2 R,3S,4S,5R,6S)-2-(hydroxymethyl)-6-((6-hydroxypyridin-3-yl)oxy)tetrahydro-2H-pyran-3,4,5-triol, named Olerapyridine (2), and two known compounds including 1H-imidazole (3) and (5S, 6 R, 7S, 8 R)-5-amino-(2Z,4Z)-1,2,3-trihydroxybuta-2,4-dienyloxy-pentane-6,7,8,9-tetraol (4) from P. oleracea for the first time. Their structures were determined by spectroscopic methods, including UHPLC-ESI-Q-TOF/MS, 1D and 2D NMR spectra. Both Olerapyrimidine and Olerapyridine at 20 μM could inhibit the inflammatory factors, IL-1β and TNF-α in the RAW 264.7 cells induced by LPS.


  • Open Access

    ONO-2506 Can Delay Levodopa-induced Dyskinesia in the Early Stage

    by Yuhao Yuan, Xiaoqian Zhang, Yi Wu, Piaopiao Lian, Xuebing Cao, Yan Xu


  • Open Access

    Enriched Environment Altered Aberrant Hippocampal Neurogenesis and Improved Long-Term Consequences After Temporal Lobe Epilepsy in Adult Rats

    by Xiaoqian Zhang, Tingting Liu, Zhike Zhou, Xiaopeng Mu, Chengguang Song, Ting Xiao, Mei Zhao, Chuansheng Zhao

    Abnormal hippocampal neurogenesis is thought to contribute to cognitive impairments in chronic temporal lobe epilepsy (TLE). Stromal cell-derived factor-1 (SDF-1) and its specific receptor CXCR4 play important roles in neurogenesis. We investigated whether enriched environment (EE) might be beneficial for TLE. Adult rats were randomly assigned as control rats, rats subjected to status epilepticus (SE), or post-SE rats treated with EE for 30 days. We used immunofluorescence staining to analyze the hippocampal neurogenesis and Nissl staining to evaluate hippocampal damage. Electroencephalography was used to measure the duration of spontaneous seizures. Cognitive function was evaluated by Morris water maze. Western blot was used to measure the expression of SDF-1 and CXCR4 in the hippocampus. In the present study, we found the TLE model resulted in aberrant neurogenesis such as reduced proliferation, intensified dendritic development of newborn neurons, as well as spontaneous seizures and cognitive impairments. More importantly, EE treatment significantly increased the cell proliferation and survival, extended the apical dendrites, and delayed the attenuation of the expression of SDF-1 and CXCR4, accompanied by decreased long-term seizure activity and improved cognitive impairments in adult rats after TLE. These results provided morphological evidence that EE might be beneficial for treating TLE.